The u.S. capnography equipment market size is expected to increase from USD 268.85 million in 2025 to USD 292.15 million in 2026 and reach USD 442.75 million by 2031, growing at a CAGR of 8.67% over 2026-2031. This report is Segmented by Product Type (Multiparameter, Standalone, Handheld), Component (Equipment, Accessories, Consumables, and Software), Technology (Mainstream, Sidestream, Microstream), Application (Anesthesia, Critical Care, Emergency Medicine, Sedation, and Respiratory), and End User (Hospitals, Ascs, and Home Healthcare). The Market Forecasts are Provided in Terms of Value (USD).
Other drivers and restraints analyzed in the detailed report include:
Handheld capnography devices are projected to grow at a 9.65% CAGR through 2031, making them the fastest-growing segment in the United States capnography equipment market. Their growth is linked to EMS procurement, ambulatory surgery use, and the adoption of continuous respiratory monitoring in home care. As portability improves and disposable designs become more user-friendly, the focus is shifting to how quickly care protocols will adapt to these advancements.
Equipment contributed 45.65% of component revenue in 2025, highlighting the importance of capital device purchases in the United States capnography equipment market. Standalone and multiparameter devices dominate, forming the core monitoring footprint in hospitals and procedural settings. Software and connectivity modules are increasingly influencing purchasing decisions due to their role in integrating with broader patient monitoring systems.
Consumables are expected to grow at a 9.55% CAGR through 2031, making them the fastest-growing component category. This growth reflects the rising installed base in hospitals, emergency departments, and ambulatory sites, driving demand for nasal cannulas, sampling lines, and airway adapters. Recurring accessory demand significantly impacts margins and customer retention, complementing the role of hardware in the market.
U.S. Capnography Equipment Market Trends and Insights
Rising Burden of COPD and Other Chronic Respiratory Conditions
The United States capnography equipment market benefits from the growing clinical burden of COPD and related respiratory disorders. In 2024, the age-adjusted COPD prevalence rate in the United States was 3.8%, with higher rates of 10.5% among adults aged 75 and older and 8.9% among those aged 65-74. Approximately 11.7 million insured individuals had a COPD diagnosis, leading to 1.8 million COPD-related acute inpatient hospitalizations. Regional disparities show higher prevalence in the South and Midwest (4.2%) compared to the West (3.1%), creating opportunities for suppliers with strong community hospital and rural system networks. The shift toward ambulatory and home settings further supports sustained demand for capnography equipment.Higher Use of Capnography in Anesthesia and Procedural Settings
Anesthesia monitoring remains a key driver in the United States capnography equipment market, contributing 34.77% of application revenue in 2025. While operating rooms are the primary demand center, growth is expanding into recovery workflows and procedural areas requiring moderate sedation. Standards for general anesthesia and airway confirmation reinforce the importance of end-tidal carbon dioxide monitoring. Additionally, the adoption of capnography by gastroenterologists, pulmonologists, radiologists, and emergency physicians broadens its demand, favoring vendors with multispecialty sales capabilities.Capital Cost and Recurring Consumables Burden
The United States capnography equipment market faces a commercial challenge as its model relies on upfront hardware investments and recurring disposable purchases. Vendor-specific accessories like Microstream™ filter lines and NomoLine sampling sets increase the total cost of ownership beyond the initial device purchase. This creates difficulties for rural hospitals and smaller facilities, which struggle to manage fleet upgrades and ongoing consumable costs compared to larger systems. Outside the operating room, limited direct billing pathways and reliance on the unlisted 94799 code, which requires case-by-case approval, further complicate adoption. Additionally, training and alarm management add operational burdens, slowing deployment in cost-sensitive settings.Other drivers and restraints analyzed in the detailed report include:
- Expansion of Emergency and Critical Care Monitoring
- Migration Toward Portable and Workflow-Integrated Monitors
- Reimbursement and Billing Friction in Non-Acute Care Settings
Segment Analysis
Standalone capnometers accounted for 52.35% of revenue in 2025, maintaining their leadership in the United States capnography equipment market. Their dominance is driven by extensive use in operating rooms, intensive care units, and emergency departments, where waveform visibility, stable performance, and monitor compatibility are critical. Hospitals prefer these devices for their seamless integration into existing monitoring systems and minimal interoperability concerns.Handheld capnography devices are projected to grow at a 9.65% CAGR through 2031, making them the fastest-growing segment in the United States capnography equipment market. Their growth is linked to EMS procurement, ambulatory surgery use, and the adoption of continuous respiratory monitoring in home care. As portability improves and disposable designs become more user-friendly, the focus is shifting to how quickly care protocols will adapt to these advancements.
Equipment contributed 45.65% of component revenue in 2025, highlighting the importance of capital device purchases in the United States capnography equipment market. Standalone and multiparameter devices dominate, forming the core monitoring footprint in hospitals and procedural settings. Software and connectivity modules are increasingly influencing purchasing decisions due to their role in integrating with broader patient monitoring systems.
Consumables are expected to grow at a 9.55% CAGR through 2031, making them the fastest-growing component category. This growth reflects the rising installed base in hospitals, emergency departments, and ambulatory sites, driving demand for nasal cannulas, sampling lines, and airway adapters. Recurring accessory demand significantly impacts margins and customer retention, complementing the role of hardware in the market.
Complete Report Scope:
- By Product Type
- Multiparameter Capnometers
- Standalone Capnometers
- Handheld Capnography Devices
- By Component
- Equipment
- Capnometers
- Monitors
- Accessories and Consumables
- Nasal Cannulas
- Sampling Lines
- Airway Adapters and Related Consumables
- Software and Connectivity
- By Technology
- Mainstream Capnography
- Sidestream Capnography
- Microstream Capnography
- By Application
- Anesthesia Monitoring
- Critical Care Monitoring
- Emergency Medicine
- Procedural Sedation
- Pain Management
- Respiratory Monitoring
- Other Applications
- By End User
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Home Healthcare Settings
- Other End Users
List of Companies Covered in this Report:
- Avante Health Solutions, LLC
- Baxter
- Beckton Dickinson
- Criticare Technologies, Inc.
- Dragerwerk AG and Co. KGaA
- EDAN Instruments, Inc.
- GE HealthCare Technologies Inc.
- Hamilton Medical
- ICU Medical
- Infinium Medical
- Koninklijke Philips
- Masimo
- Medtronic
- Mindray
- Nihon Kohden
- Nonin Medical
- Smiths Group
- Spacelabs Healthcare, LLC
- Vyaire Medical
- Zoll Medical
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET LANDSCAPE
5 MARKET SIZE AND GROWTH FORECASTS (VALUE, USD)
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Avante Health Solutions, LLC
- Baxter International Inc.
- Becton, Dickinson and Company
- Criticare Technologies, Inc.
- Dragerwerk AG and Co. KGaA
- EDAN Instruments, Inc.
- GE HealthCare Technologies Inc.
- Hamilton Medical AG
- ICU Medical, Inc.
- Infinium Medical, Inc.
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- Mindray Medical International Limited
- Nihon Kohden Corporation
- Nonin Medical, Inc.
- Smiths Group plc
- Spacelabs Healthcare, LLC
- Vyaire Medical, Inc.
- ZOLL Medical Corporation
